A2 Milk could benefit as Abbott pulls out of Chinese infant formula market

A2 Milk could benefit as Abbott pulls out of Chinese infant formula market
The US company's market share in China will be up for grabs. (Image: Getty)
Rebecca Howard
A2 Milk stands to benefit as US-based healthcare firm Abbott Laboratories phases out its infant and child nutrition business in China, but the news also underscores how tough that market is.Abbott will gradually stop making and selling baby formula under the Eleva, PediaSure, and Similac brands as well as the sub-brands of Total Comfort and NeoSure, it said on WeChat, according to news service Yicai Global.In the English translation of an internal email seen by BusinessDesk, company executives said it was a “difficult decision” that...

More Primary Sector

The simple strategy behind Dairyworks
Primary Sector

The simple strategy behind Dairyworks

Is New Zealand still fixated on the 1kg block of cheese?

Riley Kennedy 02 Apr 2025
Mineral sands miner appoints new chair for expansion era
Primary Sector

Mineral sands miner appoints new chair for expansion era

Debbie Birch joins the group as it seeks consent for a major new mine near Hokitika.

Oliver Lewis 01 Apr 2025
Who is Mainland Group's chair-elect Liz Coutts
Primary Sector

Who is Mainland Group's chair-elect Liz Coutts

From CEO at 31 to one of NZ's most sought-after directors.

Brighter times ahead for Silver Fern Farms
Primary Sector

Brighter times ahead for Silver Fern Farms

 It's Dan Boulton’s No 1 priority to get SFF back in the black.

Riley Kennedy 01 Apr 2025